NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab.

Saved in:
Bibliographic Details
Title: NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab.
Authors: Rubio-Gayarre A; Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Vinyoles M; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Tejedor JR; Institute of Oncology of Asturias (IUOPA), ISPA-HUCA, Spain., Guerrero-Murillo M; Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Fernandez-Fuentes N; Josep Carreras Leukemia Research Institute., Barcelona, Spain., Caracuel-Peramos R; GENYO. Center for Genomics and Oncological Research: Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain., Plaza-Calonge MC; GENYO. Center for Genomics and Oncological Research: Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain., Martinez-Moreno A; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine,, Barcelona, Spain., Roca-Ho H; IJC, Barcelona, Spain., Petazzi P; Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Pañella-Alférez A; GENYO. Center for Genomics and Oncological Research: Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain., Meseguer-Giron A; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Vrenken KS; Princess Maxima Center, Utrecht, Netherlands., Fraga MF; CINN-ISPA, Oviedo, Spain., Leoz Allegretti P; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Palacio-Garcia C; 4. Servei d'Hematologia, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain, Barcelona, Spain., Velasco P; Hospital Vall d'Hebrón. Universitat Autonoma de Barcelona, Barcelona, Spain., Fuster JL Sr; Hospital Clínico Universitario Virgen de la Arrixaca. Instituto Murciano de Investigación Biosanitaria (IMIB), Pilar de la Horadada. Alicante, Spain., Stam RW; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Rodríguez-Manzaneque JC; GENYO. Center for Genomics and Oncological Research: Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain., Bustelo XR; Centro de Investigacion del Cancer, Salamanca, Spain., Robles-Valero J; Centro de Investigacion del Cancer, Salamanca, Spain., Menendez P; Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Spain., Bueno C; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Lopez-Millan B; Josep Carreras Leukemia Research Institute, Barcelona, Spain.
Source: Blood [Blood] 2026 Jun 23. Date of Electronic Publication: 2026 Jun 23.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2025031693